Abstract
Introduction: Pterostilbene is a polyphenolic component that has antioxidant and anti-inflammatory properties, and the current study aims to elucidate its potential therapeutic effects on abdominal aortic aneurysm (AAA). materials and methods: The single-cell sequencing data and transcriptome datasets obtained from the Gene Expression Omnibus (GEO) database were applied to identify the differentially expressed genes (DEGs) in AAA, which were intersected with the predicted targets of Pterostilbene. The overlapping genes were defined as the core genes for functional enrichment analysis and gene set enrichment analysis (GSEA). The binding of the core genes to Pterostilbene was additionally validated in molecular docking. results: The potential target genes associated with Pterostilbene and the DEGs in AAA were identified with varied enriched pathways. 3 core genes were identified as the potential targets of Pterostilbene and the DEGs in AAA, namely, PPIA, DPP4, and ITK, which were significantly correlated with pathways like MTORC1_SIGNALING, IL6_JAK_STAT3_SIGNALING, and INFLAMMATORY_RESPONSE. GSEA indicated that these genes were enriched in pathways related to immune response and oxidative phosphorylation. Furthermore, the differential expression of the 3 core genes was observed, and the results of molecular docking demonstrated the binding affinities of Pterostilbene with the 3 core genes. discussion: This multi-omics study revealed that Pterostilbene may exert its therapeutic effects on AAA by regulating inflammation- and immune-related pathways, providing theoretical support for its further development as a therapeutic drug. conclusion: Pterostilbene may exert its therapeutic effects on AAA by modulating inflammation- and immunity-related signaling pathways and targeting the 3 core genes (PPIA, DPP4, and ITK), which warrants further investigation on the therapeutic potential.

This publication has 43 references indexed in Scilit: